- Home
- MRVI vs UMAC Comparison
MRVI vs UMAC Comparison
Compare MRVI & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- UMAC
- Stock Information
- Founded
- MRVI 2014
- UMAC 2019
- Country
- MRVI United States
- UMAC United States
- Employees
- MRVI N/A
- UMAC N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- UMAC
- Sector
- MRVI Health Care
- UMAC
- Exchange
- MRVI Nasdaq
- UMAC Nasdaq
- Market Cap
- MRVI 312.4M
- UMAC 267.7M
- IPO Year
- MRVI 2020
- UMAC 2024
- Fundamental
- Price
- MRVI $2.20
- UMAC $10.04
- Analyst Decision
- MRVI Hold
- UMAC Strong Buy
- Analyst Count
- MRVI 10
- UMAC 2
- Target Price
- MRVI $6.84
- UMAC $19.00
- AVG Volume (30 Days)
- MRVI 1.5M
- UMAC 4.8M
- Earning Date
- MRVI 08-11-2025
- UMAC 08-14-2025
- Dividend Yield
- MRVI N/A
- UMAC N/A
- EPS Growth
- MRVI N/A
- UMAC N/A
- EPS
- MRVI N/A
- UMAC N/A
- Revenue
- MRVI $241,856,000.00
- UMAC $6,988,704.00
- Revenue This Year
- MRVI N/A
- UMAC $100.69
- Revenue Next Year
- MRVI $10.70
- UMAC $93.15
- P/E Ratio
- MRVI N/A
- UMAC N/A
- Revenue Growth
- MRVI N/A
- UMAC 1029.19
- 52 Week Low
- MRVI $1.67
- UMAC $1.28
- 52 Week High
- MRVI $9.95
- UMAC $23.62
- Technical
- Relative Strength Index (RSI)
- MRVI 42.78
- UMAC 52.41
- Support Level
- MRVI $1.99
- UMAC $9.51
- Resistance Level
- MRVI $2.40
- UMAC $11.08
- Average True Range (ATR)
- MRVI 0.16
- UMAC 0.78
- MACD
- MRVI -0.06
- UMAC -0.14
- Stochastic Oscillator
- MRVI 25.15
- UMAC 45.19
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About UMAC Unusual Machines Inc. Common Stock
Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.